AETERNA ZENTARIS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.69 USD | -2.42% |
|
+15.77% | +30.24% |
| 05-29 | Ceapro's Q1 Net Loss Swells YoY, But Talks Up Benefits of Planned Aeterna Merger | MT |
| 05-17 | Aeterna Zentaris Finalizes Some Details for Ceapro Merger | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 54.63B | - | |||||
| 39.92B | ||||||
| 26.86B | ||||||
| 26.22B | ||||||
| 18.78B | - |
